|
#1
23.10.2009, 11:54
|
||||
|
||||
|
Îáçîð àìåðèêàíñêèõ êàðäèîëîãè÷åñêèõ æóðíàëîâ çà íåäåëþ (ññûëêè)
Àðèòìèè
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ñåðäå÷íî-ñîñóäèñòàÿ õèðóðãèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Âðîæäåííûå ïîðîêè ñåðäöà [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Îáùàÿ êàðäèîëîãèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ñåðäå÷íàÿ íåäîñòàòî÷íîñòü/òðàíñïëàíòàöèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Èíòåðâåíöèîííàÿ êàðäèîëîãèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Íåèíâàçèâíàÿ êàðäèîëîãèÿ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Ïðîôèëàêòèêà/ñîñóäû [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Defibrillator Implantation Early After Myocardial Infarction Steinbeck G, Andresen D, Seidl K, et al., on behalf of the IRIS Investigators. N Engl J Med 2009;361:1427-1436. Study Question: Do implantable cardioverter defibrillators (ICDs) improve survival when implanted in high-risk patients within 1 month of a myocardial infarction (MI)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Long-Term Results of Catheter-Based Treatment of Pulmonary Atresia and Intact Ventricular Septum Marasini M, Gorrieri PF, Tuo G, et al. Heart 2009;95:1520-1524. Study Question: What are the outcomes of patients with pulmonary atresia with intact ventricular septum (PAIVS) after interventional perforation of the pulmonary valve? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] A Meta-Analysis of Remote Monitoring of Heart Failure Patients Klersy C, De Silvestri A, Gabutti G, Regoli F, Auricchio A. J Am Coll Cardiol 2009;54:1683-1694. Study Question: What is the effect of remote patient monitoring (RPM) on the outcome of chronic heart failure (HF) patients? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Hospitalizations After Heart Failure Diagnosis: A Community Perspective Dunlay SM, Redfield MM, Weston SA, et al. J Am Coll Cardiol 2009;54:1695-1702. Study Question: What is the lifetime burden and risk factors for hospitalization after heart failure (HF) diagnosis in the community? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients Mazzaglia G, Ambrosioni E, Alacqua M, et al. Circulation 2009;120:1598-1605. Study Question: What are the predictors of adherence to antihypertensive treatment and the association of adherence with acute cardiovascular events? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Neighborhood Resources for Physical Activity and Healthy Foods and Incidence of Type 2 Diabetes Mellitus: The Multi-Ethnic Study of Atherosclerosis Auchincloss AH, Diez Roux AV, Mujahid MS, et al. Arch Intern Med 2009;169:1698-1704. Study Question: Are neighborhood resources associated with incidence of type 2 diabetes mellitus (DM)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-Analyses for the U.S. Preventive Services Task Force Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. Ann Intern Med 2009;151:483-495. Study Question: C-reactive protein (CRP) may help to refine global risk assessment for coronary heart disease (CHD), particularly among persons who are at intermediate risk on the basis of traditional risk factors alone. Should CRP be incorporated into guidelines for CHD risk assessment? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force Helfand M, Buckley DI, Freeman M, et al. Ann Intern Med 2009;151:496-507. Study Question: Traditional risk factors do not explain all of the risk for incident coronary heart disease (CHD) events. What is the evidence of value of new or emerging risk factors for improving global risk assessment for CHD? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Myeloperoxidase, Subclinical Atherosclerosis, and Cardiovascular Disease Events Wong ND, Gransar H, Narula J, et al. JACC Cardiovasc Img 2009;2:1093-1099. Study Question: Myeloperoxidase (MPO) is a leukocyte-derived enzyme-generating reactive oxidant species that has been shown to predict risk of cardiovascular disease (CVD) in selected populations. Does MPO predict future CVD events in asymptomatic adults, and does subclinical atherosclerosis affect this relation? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Vardenafil Treatment for Patients With Pulmonary Arterial Hypertension: A Multicentre, Open-Label Study Jing ZC, Jiang X, Wu BX, et al. Heart 2009;95:1531-1536. Study Question: What are the long-term effects of vardenafil, a phosphodiesterase-5 (PDE-5) inhibitor, in patients with pulmonary arterial hypertension (PAH)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] 
|
|
#2
23.10.2009, 19:32
|
||||
|
||||
|
MitraClip for High Risk Patients
Hospital to Home - New Health Care Initiative Pediatric IMPACT Registry [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Three-year efficacy of complex insulin regimens in Type 2 DM (N Engl J Med). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Use of aldosterone antagonists in HF (JAMA). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#3
29.10.2009, 20:48
|
||||
|
||||
|
Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm: A Randomized Trial
Lederle FA, Freischlag JA, Kyriakides TC, et al., for the Open Versus Endovascular Repair (OVER) Veterans Affairs Cooperative Study Group. JAMA 2009;302:1535-1542. Open Versus Endovascular Repair (OVER) Study Question: In the Veterans Affairs (VA) medical centers, what are the short-term (2-year) outcomes following open and endovascular (EVAR) abdominal aortic aneurysm (AAA) repair? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Sex-Specific Trends in Midlife Coronary Heart Disease Risk and Prevalence Towfighi A, Zheng L, Ovbiagele B. Arch Intern Med 2009;169:1762-1766. Study Question: What is the sex-specific midlife prevalence of myocardial infarction (MI) and risk of coronary heart disease (CHD)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients The RENAL Replacement Therapy Study Investigators. N Engl J Med 2009;361:1627-1638. Study Question: What is the optimal intensity of renal-replacement therapy in patients with acute kidney injury who are critically ill? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] High Prevalence of Abnormal Nocturnal Oximetry in Patients With Hypertrophic Cardiomyopathy Eleid MF, Konecny T, Orgban M, et al. J Am Coll Cardiol 2009;54:1805-1809. Study Question: What is the prevalence of nocturnal oxygen desaturation and obstructive sleep apnea (OSA) in a population of patients with hypertrophic cardiomyopathy (HCM)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Use of Aldosterone Antagonists in Heart Failure Albert NM, Yancy CW, Liang L, et al. JAMA 2009;302:1658-1665. Study Question: How often are aldosterone antagonists prescribed based on heart failure (HF) management guideline criteria and investigator-defined appropriateness criteria, and what are the trends over time in patients hospitalized with HF? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Effects of Liraglutide in the Treatment of Obesity: A Randomised, Double-Blind, Placebo-Controlled Study Astrup A, Rössner S, Van Gaal L, et al., on behalf of the NN8022-1807 Study Group. Lancet 2009;Oct 23:[Epub ahead of print]. Study Question: Liraglutide, a glucagon-like peptide-1 (GLP-1) administered subcutaneously once daily, is effective in diabetes and induces weight loss. What is the effect of liraglutide on bodyweight and tolerability in obese individuals without type 2 diabetes? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Three-Year Efficacy of Complex Insulin Regimens in Type 2 Diabetes Holman RR, Farmer AJ, Davies MJ, et al., for the 4-T Study Group. N Engl J Med 2009;361:1736-1747. Study Question: What is the relative value of specific insulin regimens superimposed on oral therapy in patients with type 2 diabetes mellitus? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement U.S. Preventive Services Task Force. Ann Intern Med 2009;151:474-482. Study Question: Are nontraditional risk factors recommended in screening for coronary heart disease (CHD)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Reducing Psychosocial Stress: A Novel Mechanism of Improving Survival From Exercise Training Milani RV, Lavie CJ. Am J Med 2009;122:931-938. Study Question: Does reducing psychosocial stress by exercise training improve survival among cardiac patients? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Role of Lifestyle and Aging on the Longitudinal Change in Cardiorespiratory Fitness Jackson AS, Sui X, Hebert JR, Church TS, Blair SN. Arch Intern Med 2009;169:1781-1787. Study Question: What is the impact of lifestyle and aging on longitudinal trends in cardiorespiratory fitness? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#4
30.10.2009, 21:23
|
||||
|
||||
|
Pinnacle Network: Best Practices and Survival Tools
Perspectives on Comparative Effectiveness Abnormal Oximetry and HCM [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Implantation of the Melody Transcatheter Pulmonary Valve in Patients With a Dysfunctional Right Ventricular Outflow Tract Conduit: Early Results From the U.S. Clinical Trial (J Am Coll Cardiol). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm: A Randomized Trial (JAMA). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Role of Lifestyle and Aging on the Longitudinal Change in Cardiorespiratory Fitness (Arch Intern Med). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#5
05.11.2009, 22:07
|
||||
|
||||
|
N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation. The Cardiovascular Health Study
Patton KK, Ellinor PT, Heckbert SR, et al. Circulation 2009;120:1768-1774. Study Question: Is N-terminal pro-B-type natriuretic peptide (NT-proBNP) a risk factor for atrial fibrillation (AF)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Aortic Valve Replacement: A Prospective Randomized Evaluation of Mechanical Versus Biological Valves in Patients Ages 55 to 70 Years Stassano P, Di Tommaso L, Monaco M, et al. J Am Coll Cardiol 2009;54:1862-1868. Study Question: What are the long-term results after tissue versus mechanical aortic valve replacement (AVR) in patients ages 55-70 years? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Pulmonary Embolism and Deep Venous Thrombosis in Trauma: Are They Related? Velmahos GC, Spaniolas K, Tabbara M, et al. Arch Surg 2009;144:928-932. Study Question: In an academic, level 1 trauma center, what is the incidence in trauma patients undergoing computed tomography (CT) for pulmonary embolism (PE) and deep venous thrombosis (DVT)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Implantation of the Melody Transcatheter Pulmonary Valve in Patients With a Dysfunctional Right Ventricular Outflow Tract Conduit: Early Results From the U.S. Clinical Trial Zahn EM, Hellenbrand WE, Lock JE, McElhinney DB. J Am Coll Cardiol 2009;54:1722-1729. Study Question: What is the safety, procedural success rate, and short-term effectiveness of the Melody transcatheter pulmonary valve in patients with dysfunctional right ventricular outflow tracts (RVOT)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease: A Randomized Controlled Trial Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. JAMA 2009;302:1651-1657. Study Question: Do omega-3 fatty acids augment sertraline in the treatment of depression in patients with coronary heart disease (CHD)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Pfeffer MA, Burdmann EA, Chen CY, et al., on behalf of the TREAT Investigators. N Engl J Med 2009;Oct 30:[Epub ahead of print]. Study Question: What is the effect of darbepoetin alfa on clinical outcomes in patients with type 2 diabetes, chronic kidney disease, and anemia? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Fleischmann KE, Beckman JA, Buller CE, et al. J Am Coll Cardiol 2009;54:2102-2128. Perspective: The following are 10 points to remember about the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) Focused Update on Perioperative Beta Blockade [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Association of Chronic Kidney Disease With the Spectrum of Ankle Brachial Index: The CHS (Cardiovascular Health Study) Ix JH, Katz R, De Boer IH, et al. J Am Coll Cardiol 2009;54:1176-1184. Study Question: What is the association between chronic kidney disease (CKD) and ankle-brachial index (ABI)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Non-Cardiac Surgery and Antiplatelet Therapy Following Coronary Artery Stenting Luckie M, Khattar RS, Fraser D. Heart 2009;95:1303-1308. Perspective: The following are 10 points to remember about this article [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Risks of Complications by Attending Physicians After Performing Nighttime Procedures Rothschild JM, Keohane CA, Rogers S, et al. JAMA 2009;302:1565-1572. Study Question: Does being on call the night before impact the outcome of procedures performed by attending physicians? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Bivalirudin in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction (HORIZONS-AMI): 1-Year Results of a Randomised Controlled Trial Mehran R, Lansky AJ, Witzenbichler B, et al., on behalf of the HORIZONS-AMI Trial Investigators. Lancet 2009;374:1149-1159. Study Question: What is the 1-year outcome of patients undergoing primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) who are treated with bivalirudin compared with those who are treated with glycoprotein IIb/IIIa inhibitors (GPIs)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#6
06.11.2009, 19:55
|
||||
|
||||
|
Early ICD Use After MI
Breaking News: ACC Responds to Final Medicare Rule CRT Reduces CHF Events [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Long-term results after tissue vs. mechanical AVR (J Am Coll Cardiol). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Use of ESAs in anemic patients with diabetes and CKD (TREAT). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Just Published: 2009 ACCF/AHA Focused Update on Perioperative Beta Blockade. Read the "10 Points to Remember" journal scan. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Analyze This Image: Surface 12-Lead ECG From a 69-Year-Old Female With Idiopathic Nondilated Cardiomyopathy and Stable Heart Failure. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New Case Study: A 39-Year-Old Woman Presents With Shortness of Breath and Palpitations for 2 Days. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New Expert Opinion: Dr. Dominick J. Angiolillo on Pharmacogenetics in Cardiovascular Antithrombotic Therapy. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New Conversations with Experts: Drs. Alan H. Gradman and Matthew R. Weir on Role of Anti-Renin Agents. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#7
13.11.2009, 21:13
|
||||
|
||||
|
MADIT-CRT
Fighting for Patient Access Niacin Decreases Carotid Disease [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertension (J Am Coll Cardiol). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Statin use and risk of gallstone disease followed by cholecystectomy (JAMA). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Angioplasty and stenting for renal artery lesions (ASTRAL). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Randomized on/off bypass trial (ROOBY). [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Cardiosource coverage of AHA Scientific Sessions 2009 begins Sunday, November 15th: Stay tuned for the latest news, including results from RE-LY, HEAAL, ARBITER 6-HALTS and more! [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New Case Study: A 61-Year-Old Patient With Hyperlipidemia Presents With Atypical Chest Pain. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New Expert Opinion: Overcoming the Barriers to Stem Cell Therapy. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
|
|
#8
15.11.2009, 19:26
|
||||
|
||||
|
CHAMPION PCI and CHAMPION PLATFORM
Among patients undergoing PCI for a variety of indications in the CHAMPION PCI and CHAMPION PLATFORM trials, the use of intravenous cangrelor was not superior to clopidogrel 600 mg, either started before or after the procedure [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ACC Launches CV Practice Network Cardiovascular practices face myriad challenges in today's health care environment — legislative and regulatory threats to payment, demands to demonstrate performance and justify clinical decisions, the emergence of reimbursement models based on efficiency or value, and the rise of new and untested business arrangements. To address these challenges, the ACC last month launched the PINNACLE Network™ [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] PLATO: Treatment with ticagrelor reduces CV death, MI, and stroke in STEMI patients. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] NCDR® Presents 14 Abstracts at AHA : The American Heart Association accepted 14 NCDR abstracts for presentation at the Annual Scientific Sessions. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] POPULAR: In patients undergoing elective PCI, several platelet function tests can help predict one-year thrombosis but not bleeding events. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#9
16.11.2009, 21:37
|
||||
|
||||
|
AHA 2009 Meeting Coverage: Daily Wrap-up for Sunday
For more video coverage, visit the AHA 2009 channel [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ARBITER 6-HALTS This trial showed that, among CHD patients on statin therapy, use of extended-release niacin caused a significant regression in carotid intima-media thickness. This agent was also superior to ezetimibe in reducing MACE and raising HDL cholesterol. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] New EHR Resource Available Confused about what you should be looking for in an electronic health record (EHR) for your cardiology practice? The ACC recently published a new resource to assist cardiovascular practices in implementing an EHR. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] TREAT: Darbepoetin Alfa in Diabetic Patients With Chronic Kidney Disease Appears to Increase Stroke Risk [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] MASS-DAC Registry: MI and Death Rate Similar for PCI at Centers Without Surgery On-Site, but Increased Revascularizations at One Year [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] RE-LY: Dabigatran 150 mg is Superior to Warfarin in Reducing Stroke or Systemic Embolism in AF Patients [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] PACE: In Patients With Normal Ventricular Function, RV Apical Pacing Results in Adverse LV Remodeling and Reduction in LVEF, Prevented by Biventricular Pacing [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Record-AF: Rhythm-Control Strategy is Preferred Therapeutic Option in Registry of Patients With Paroxysmal and Persistent AF [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#10
17.11.2009, 20:26
|
||||
|
||||
|
AHA 2009 Meeting Coverage: Daily Wrap-up Monday
For more video coverage, visit the AHA 2009 channel. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] HEAAL Losartan 150 mg daily reduces all-cause mortality and HF admission in patients with HF, reduced LVEF, and intolerance to ACE inhibitors, compared with losartan 50 mg daily. Although beneficial, high-dose losartan results in more adverse events: hyperkalemia, hypotension, renal insufficiency, and angioedema. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] FAIR-HF: Treatment With Intravenous Iron in Patients With ron in Patients With CHF and Iron Deficiency Improves Symptoms, Functional Capacity, and Quality of Life [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Heart Mate II: Continuous-Flow LV Assist Devices in Patients With Advanced HF Significantly Reduces Stroke and Device Failure Compared With Pulsatile Devices [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Bypassing the Blues: Telephone-Delivered Collaborative Care for Treating Post-CABG Depression Results in Improved Health-Related Quality of Life, Physical Functioning, and Mood Symptoms [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] CASCADE: After CABG, the Addition of Clopidogrel to Aspirin Does Not Significantly Reduce Vein Graft Intimal Hyperplasia or Improve Graft Patency [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] OCTOPUS: After 7.5 Years, Off-Pump CABG Has Comparable Safety Profile as PCI, Lower Risk of Coronary Reinterventions, and Possibly Better Cognitive Performance [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] POPE: Treatment With NSAIDs in Patients With Moderate to Large Postoperative Pericardial Effusion Does Not Reduce Pericardial Effusion [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#11
19.11.2009, 12:44
|
||||
|
||||
|
AHA 2009 Meeting Coverage: Daily Wrap-up Tuesday
For more video coverage, visit the AHA 2009 channel. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ACCF, AHA Unveil Updated Guidelines for PCI The ACCF, along with the AHA and the Society for Cardiovascular Angiography and Interventions, today is releasing a focused update that applies to two sets of Guidelines — the management of patients with STEMI and the management of patients undergoing PCI. Continue Reading. See also the "10 Points to Remember" journal scan and video interview with Dr. Kushner. [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] BARI 2D: Quality of Life Results, Economic Outcomes, and 5-Year Results [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] J-CHF: No Difference in Clinical Outcomes for 3 Doses of Carvedilol in Patients With Chronic Stable HF [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#12
20.11.2009, 19:51
|
||||
|
||||
|
Predictors of Sudden Cardiac Death Change With Time After Myocardial Infarction: Results From the VALIANT Trial
Piccini JP, Zhang M, Pieper K, et al. Eur Heart J 2009;Oct 23:[Epub ahead of print]. Study Question: Do risk factors for sudden cardiac death (SCD) change over time after myocardial infarction (MI)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Biventricular Pacing in Patients With Bradycardia and Normal Ejection Fraction Yu CM, Chan JY, Zhang Q, et al. N Engl J Med 2009;Nov 15:[Epub ahead of print]. Study Question: Does biventricular pacing prevent the deleterious effects of right ventricular (RV) apical pacing in patients with a normal ejection fraction (EF)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Revascularization Versus Medical Therapy for Renal-Artery Stenosis The ASTRAL Investigators. N Engl J Med 2009;361:1953-1962. Study Question: What are the clinical benefits of percutaneous renal artery revascularization compared with modern, best medical therapy? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Long-Term Prognostic Value of ST-Segment Resolution in Patients Treated With Fibrinolysis or Primary Percutaneous Coronary Intervention: Results From the DANAMI-2 (DANish trial in Acute Myocardial Infarction-2) Sejersten M, Valeur N, Grande P, Nielsen TT, Clemmensen P, on behalf of the DANAMI-2 Investigators. J Am Coll Cardiol 2009;54:1763-1769. Study Question: What is the prognostic value of ST-segment resolution after primary percutaneous coronary intervention (pPCI) versus fibrinolysis? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Statin Use and Risk of Gallstone Disease Followed by Cholecystectomy Bodmer M, Brauchli YB, Krahenbuhl S, Jick SS, Meier CR. JAMA 2009;302:2001-2007. Study Question: What is the association between the use of statins, fibrates, or other lipid-lowering agents and the risk of incident gallstone disease followed by cholecystectomy? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Simple Versus Complex Stenting Strategy for Coronary Artery Bifurcation Lesions in the Drug-Eluting Stent Era: A Meta-Analysis of Randomised Trials Zhang F, Dong L, Ge J. Heart 2009;95:1676-1681. Study Question: What is the best strategy for interventional treatment of coronary bifurcation lesions in patients treated with drug-eluting stents (DES)? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Long-Term Effects of a Very Low-Carbohydrate Diet and a Low-Fat Diet on Mood and Cognitive Function Brinkworth GD, Buckley JD, Noakes M, Clifton PM, Wilson CJ. Arch Intern Med 2009;169:1873-1880. Study Question: Is psychological function affected by a very low-carbohydrate diet used to promote weight loss? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] The Relative Efficacy and Safety of Clopidogrel in Women and Men: A Sex-Specific Collaborative Meta-Analysis Berger JS, Bhatt DL, Cannon CP, et al. J Am Coll Cardiol 2009;54:1935-1945. Study Question: Are there gender-related differences in the efficacy and safety of clopidogrel? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Major Lipids, Apolipoproteins, and Risk of Vascular Disease The Emerging Risk Factors Collaboration. JAMA 2009;302:1993-2000. Study Question: What major lipids are most clearly associated with vascular disease? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#13
20.11.2009, 20:08
|
||||
|
||||
|
NCDR Highlights from AHA 2009
High LDL Levels in U.S. Population Drop Significantly [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Cardiosource has full coverage of AHA Scientific Sessions 2009, including results from: ARBITER 6-HALTS: Extended-release niacin superior to ezetimibe as add-on to statin therapy [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] HEAAL: High-dose losartan reduces all-cause mortality, HF hospitalization [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] CHAMPION PCI and CHAMPION PLATFORM: Intravenous cangrelor not superior to clopidogrel for patients undergoing PCI [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] RE-DEEM: Dabigatran With Dual-Antiplatelet Therapy after STEMI and NSTEMI Is Well Tolerated, With Relatively Low Bleeding [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] ALLHAT: 10-Year Outcome Treatment Difference Shows Chlorthalidone Is Favored Over Amlodipine for Preventing HF [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] CT-STAT: CT angiography triages at-risk chest-pain patients quicker and cheaper than standard stress testing [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#14
29.11.2009, 13:10
|
||||
|
||||
|
Trends in High Levels of Low-Density Lipoprotein Cholesterol in the United States, 1999-2006
Study Question: Has there been a change in screening prevalence, use of cholesterol-lowering medication, and low-density lipoprotein cholesterol (LDL-C) levels in the United States between 1999 and 2006? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] Telephone-Delivered Collaborative Care for Treating Post-CABG Depression: A Randomized Controlled Trial Study Question: What is the effectiveness of telephone-delivered collaborative care for post-coronary artery bypass grafting (CABG) depression versus usual physician care? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease Study Question: What are the prognostic implications of elevated troponin T levels in stable coronary disease patients? [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
|
#15
29.11.2009, 13:39
|
||||
|
||||
|
Braunwald's Heart Disease e-dition, Eighth Edition:
Text with Continually Updated Online Reference By Peter Libby, MD, Robert O. Bonow, MD, Douglas P. Zipes, MD and Douglas L. Mann, MD, FACC E-dition editor, Eugene Braunwald, MD [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
|
Ëèíåéíûé âèä
